Who invested in OncoLens

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$17Mraised across 2 rounds since 2019, from 2 sources

$1.4MSeed$16MSeries B

Latest round: Series B, $16MOct 2024
Step-upi: 11.9×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021202220232024

$1.4MSeed$16MSeries B

First round: Seed, $1.4M
Biggest round: $16M
Between rounds: 5.5 years

The rounds

Oct 2024
Series B$16M1 new
- B Capital
Source recorded
Mar 2019
Seed$1.4M2 new
- BIP Capital
- Atlanta Technology Angels
Reported by FinSMEs

Founders and team

From OncoLens's own website: 1 founder, 5 on the team.

Anju MathewCo-founder and Chief Executive Officer

Todd GrantChief Financial Officer
James NoeVP of Business Development, Life Science Partnerships
Donna ParrBoard Member
Jack MatkinsBoard Member
Mark BuffingtonBoard Member

AdvisersJane McCracken

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2019Series B2024

B Capital

BIP Capital

Atlanta Technology Angels

Everyone who backed them

B CapitalVC firm1round

BIP CapitalVC firm1round

Atlanta Technology AngelsAngel network1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists OncoLens as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.